v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss from ongoing operations $ (1,124,743) $ (9,800,041)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on sale of securities (2,176) (175)
Loss on fair market value of equity investments 1,597 899
Gain on fair market value of derivatives (1,284,000) (61,000)
Loss on fair market value of warrants 7,094,000
Share-based compensation:    
To directors – options 62,753 189,350
To key employees - options 12,229 298,755
To non-employees - options 9,654 29,260
Deposits and other receivables (2,482)
Prepaid expenses (4,594) 168,066
Trade and other payables (308,478) 145,014
Right-of-use liabilities (404)
Deferred Compensation Payable 179,077
Net cash used by operating activities (2,640,240) (1,757,199)
Cash flows from investing activities:    
Purchases of marketable securities (5,859,483) (18,306)
Proceeds from sale of marketable securities 8,399,813 750,330
Net cash provided by investing activities 2,540,330 732,024
Cash flows from financing activities    
Redemption of Series F Convertible Preferred Stock (73,472)
Dividends on Series F Convertible Preferred Stock (1,288,604)
Premium on Series F Convertible Preferred Stock (68,104)
Net cash used in financing activities (1,430,180)
Net decrease in cash and restricted cash (99,910) (2,455,355)
Cash and restricted cash at beginning of period 173,154 2,681,010
Cash and restricted cash at end of period 73,244 225,655
Supplemental cash flow information    
Interest
Income Taxes
Supplemental Schedule of Non-Cash Financing and Investing Activities    
Reclass of warrant liability upon warrant modification 7,961,000
Fair value of Series G Convertible Preferred Stock issued in-lieu of dividends $ 656,000

Source